Investment Rating - The report maintains a "Buy" rating for the company with a target price of 43.0 HKD [7][8]. Core Views - The company reported Q1 2025 revenue of 541 million USD, a year-over-year increase of 17.6% and a quarter-over-quarter increase of 0.3%, driven by increased wafer shipments [16][20]. - The gross margin for Q1 2025 was 9.2%, up 2.8 percentage points year-over-year but down 2.2 percentage points quarter-over-quarter due to depreciation from new production lines [16][20]. - The company expects Q2 2025 revenue to be between 550 million and 570 million USD, with a gross margin guidance of 7% to 9% [21]. Summary by Sections Revenue and Profitability - Q1 2025 revenue reached 541 million USD, with wafer shipments of 1.231 million pieces, reflecting a 20% year-over-year increase [16][20]. - The company anticipates a stable ASP (Average Selling Price) throughout the year, with potential for price increases in 12-inch products as capacity ramps up [3][5]. Capacity and Production - The production capacity utilization rate was 102.7% in Q1 2025, with the second 12-inch production line expected to ramp up steadily [2][21]. - The company plans to shorten ramp-up times and increase shipment volumes to stabilize gross margins [2]. Market Trends and Product Segments - The company is benefiting from local production trends accelerated by tariffs, particularly in the analog and power management segments, which saw a 34.8% year-over-year revenue increase [4][26]. - The 12-inch wafer segment generated 310 million USD in Q1 2025, a 40.8% year-over-year increase, while the 8-inch segment saw a decline [24][22]. Financial Forecasts - The report projects revenue growth of 8.2%, 13.1%, and 11.7% for 2025, 2026, and 2027, respectively, with net profit estimates of 52 million, 82 million, and 97 million USD for the same years [18][19]. - The target price of 43.0 HKD is based on a 1.5x multiple of the 2025 estimated book value per share [5][29].

[Table_Title] 证券研究报告 / 港股公司报告 从韩束到多点开花，领先国货集团迈向新征程 报告摘要： [Table_Summary] 上美股份：深耕美妆二十余载，打造国货领先美妆集团。公司历史可追 溯到 2002 年，公司创始人吕义雄先生开始在上海从事化妆品行业，随后 在 2003 年创立第一个自主品牌—韩束，此后陆续创立一叶子、红色小 象、极方、一页、安敏优等品牌。目前公司正筹备打造高端抗衰护肤品 牌 TAZU、母婴护理品牌面包超人、彩妆品牌 NAN beauty，持续完善品 牌及产品矩阵，延续集团稳健增长势能。 多品类+多渠道+多品牌，迈向集团发展新阶段。公司 2023 年业绩的陡 然提升离不开对抖音短剧的敏锐发掘，一方面可以看出公司深耕市场历 练出了灵活的战略调整能力和对市场的深刻理解，同时也奠定了公司在 美妆行业的领先优势。公司将进一步突破品牌及集团的天花板，韩束产 品类型由套装向大单品延展，渠道由抖音向天猫等布局，目前 X 肽及次 抛大单品表现优异，天猫渠道已逐步起量；此外公司加紧子品牌打造， 依托自身研发优势和营销优势，为子品牌充分赋能，接力推动集团业绩 再上台阶。长远来看，公司战略规 ...

Investment Rating - The investment rating for the company is "Buy" with a target price not specified in the report [3][4]. Core Viewpoints - The company has signed a share acquisition agreement with TH Tong Heng Machinery, the largest comprehensive equipment leasing company in Malaysia, to acquire 80% of its shares, which is expected to enhance market share and competitiveness in Malaysia [1][2]. - The acquisition price is approximately RMB 300 million, corresponding to about 1.76 billion MYR, which is considered reasonable at about 6 times EBITDA, with the target company's revenue compound annual growth rate projected at 31% from 2021 to 2024 [2]. - The company is optimizing its asset structure and controlling capital expenditures, which is expected to improve asset return rates and enhance overseas operational performance [3]. Summary by Sections Acquisition Details - The acquisition of TH Tong Heng Machinery is a strategic move to deepen the company's presence in the Malaysian market, leveraging a stable customer base of over 1,000 clients [1]. - The remaining 20% of shares will be priced based on future long-term operating performance [1]. Financial Performance - The target company reported total assets of 163 million MYR and net assets of 91.9 million MYR as of the end of 2024, indicating strong financial health [2]. - The company's EBITDA margin and net profit margin for 2024 are projected to be 70% and 28.3%, respectively [2]. Operational Efficiency - The company's rental rates for key equipment categories have been increasing, with a reported rental rate of approximately 78% for aerial work platforms by the end of Q1 2025 [3]. - The overseas business revenue has significantly increased, accounting for over 15% of total revenue, indicating successful global expansion efforts [3]. Future Projections - The company expects net profits for the years 2025 to 2027 to be 1.02 billion, 1.15 billion, and 1.3 billion RMB, respectively, with corresponding price-to-earnings ratios of 3.6, 3.2, and 2.8 times [3].

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Viewpoints - The controlling shareholder has signed a framework agreement with Japan's TDK to acquire its micro motor business, which includes over 2,000 patents, more than 2,000 employees, and a well-experienced R&D team [1] - The acquisition is expected to enhance the controlling shareholder's high-end micro motor product line, positioning it as a global leader covering the entire product range from high to low-end micro motors [1] - The company's vertical integration capabilities in the camera module supply chain are expected to improve, enhancing long-term profitability [2] - The company has initiated the "Apollo" plan to promote vertical integration of core components in camera modules through partnerships and resources from the controlling shareholder [2] Summary by Sections Camera Module Shipment and Product Structure - From January to April, the shipment volume of camera modules decreased by 16.5% year-on-year, but the proportion of 32MP and above camera modules increased by 9.1 percentage points to 56.5%, indicating a significant optimization in product structure [3] - The fingerprint recognition module shipment increased by 83.1% year-on-year, driven by improved supply-demand dynamics and product structure optimization [3] Financial Forecasts and Valuation - The net profit forecasts for 2025 and 2026 have been raised by 24% and 17% to RMB 602 million and RMB 713 million, respectively, with a new forecast for 2027 at RMB 840 million [3] - Revenue projections for 2023 to 2027 are as follows: RMB 12,530.8 million in 2023, RMB 16,151.3 million in 2024, RMB 19,377.2 million in 2025, RMB 21,701.0 million in 2026, and RMB 23,936.3 million in 2027 [4][10]

Investment Rating - The report maintains a "Buy" rating for Huahong Semiconductor (1347.HK) [6] Core Views - The company achieved revenue of $541 million in Q1 2025, a year-on-year increase of 17.6% and a quarter-on-quarter increase of 0.3%, aligning with the company's guidance of $530 to $550 million [1] - The overall demand is expected to gradually recover, with structural growth in demand for products such as analog and power management due to US-China tariff policies [2] - The company is accelerating capacity expansion, with monthly production capacity expected to reach 40,000 wafers by the end of 2025 [3] - The forecast for net profit has been revised downwards for 2025-2027 due to increased depreciation pressure from accelerated capacity expansion, with expected net profits of $80 million, $180 million, and $270 million respectively [4] Summary by Sections Financial Performance - Q1 2025 revenue was $541 million, with 8-inch wafer revenue at $230 million (down 4% YoY) and 12-inch wafer revenue at $310 million (up 41% YoY) [1] - Q1 2025 gross margin was 9.2%, slightly above the lower end of the guidance range of 9%-11%, with a year-on-year increase of 2.8 percentage points [1] Demand and Market Outlook - The company expects a gradual recovery in downstream demand, with electronic consumer goods revenue accounting for 64.3% of total revenue, growing 20.9% YoY [2] - The ASP for 12-inch wafers shows signs of price increases, while the 8-inch wafer ASP is stabilizing but lacks upward momentum [2] Capacity Expansion - Huahong Semiconductor is actively advancing the construction of new manufacturing facilities, with a projected monthly capacity of 40,000 wafers by the end of 2025 [3] - Capital expenditures in Q1 2025 amounted to $510.9 million, with significant investments in 12-inch wafer production [3] Profit Forecast and Valuation - The net profit forecast for 2025-2027 has been adjusted downwards, reflecting increased depreciation pressure from capacity expansion [4] - The current stock price corresponds to a P/E ratio of 94x for 2025 and 41x for 2026, indicating a favorable long-term growth outlook supported by capacity expansion [4]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price raised to HKD 37.5, reflecting a potential upside of 15.6% from the current price of HKD 32.45 [1][3][7]. Core Insights - The company reported a 1Q25 revenue of USD 541 million, a year-on-year increase of 17.6%, driven by a 42% increase in wafer shipments, despite ongoing price pressures [1]. - The gross margin for 1Q25 was 9.2%, which is below market expectations and the guidance range, but improved from 6.4% in the same quarter last year [1]. - Management expects 2Q25 revenue to be in the range of USD 550-570 million, indicating a 17% year-on-year growth [1]. - The semiconductor industry is expected to benefit from accelerated domestic substitution processes amid increasing geopolitical risks [1][7]. Financial Summary - For FY25E, the company is projected to achieve revenue of USD 2.317 billion, reflecting a 15.6% year-on-year growth, with gross margins expected to recover to 10.6% [2][8]. - The net profit for FY25E is estimated at USD 24 million, a significant decrease from the previous year, but expected to rebound in FY26E to USD 253 million [2][8]. - The company’s capacity utilization rates remain high at 100% for 8-inch and 105% for 12-inch factories, with new capacity expected to contribute from 1Q25 [7][8]. Market Position - Approximately 82% of the company's revenue comes from China, with 9.4% from North America, positioning it well to benefit from domestic demand for semiconductor manufacturing [7]. - The report highlights that the company is likely to maintain high utilization rates post new capacity deployment, driven by increasing domestic chip manufacturing needs [7].

Investment Rating - The investment rating for WuXi AppTec (02268.HK) is "Outperform the Market" [6][4] Core Views - The company achieved impressive growth in 2024, with a main business revenue of 40.52 billion yuan (+90.8%) and a net profit attributable to shareholders of 10.70 billion yuan (+277.2%) [2][9] - The gross margin for 2024 was 30.6% (+4.3 percentage points), and the net profit margin was 26.4% (+13.3 percentage points), indicating a significant improvement in profitability [2][9] - The company has a strong order backlog of 9.91 billion USD (+71.2%) and has expanded its customer base to 499 clients (+44.5%), including 13 of the top 20 global pharmaceutical companies [2][17] Summary by Sections Financial Performance - In 2024, the company reported a main business revenue of 40.52 billion yuan, a 90.8% increase from the previous year, and a net profit of 10.70 billion yuan, reflecting a 277.2% growth [2][9] - Non-IFRS adjusted net profit reached 11.74 billion yuan, up 184.8% [2][9] - The company’s gross margin improved to 30.6%, and net profit margin increased to 26.4% [2][9] Order and Client Growth - The company’s order backlog reached 9.91 billion USD, marking a 71.2% increase [2][17] - The number of clients grew to 499, with a 44.5% increase, including 13 of the top 20 global pharmaceutical companies contributing 32.0% of revenue [2][17] Technological Advancements - The WuXiDARx™ technology has supported 45 preclinical candidates and 7 clinical projects, enhancing the company's capabilities in ADC and XDC drug services [3][21] - The company has completed 83 IND submissions for ADC and 2 for XDC, with 34 projects in late-stage clinical development [3][21] Capacity Expansion - The company is actively expanding its global production capacity, with new production lines in Wuxi and Shanghai expected to enhance service capabilities in the European and American markets [3][22] - The second production line in Wuxi is set to commence operations in November 2024, and further expansions are planned for 2025 and 2026 [3][22]

Investment Rating - The report maintains a "Buy-A" rating for the company, indicating a positive outlook for its stock performance [2][7]. Core Insights - The company has shown a steady growth in its biological compound fertilizer segment, benefiting from rising potassium fertilizer prices. In 2024, the company achieved a revenue of 21.265 billion yuan, a slight decrease of 2.1% year-on-year, while net profit increased significantly by 69.7% to 1.061 billion yuan [3][4][5]. Summary by Sections Financial Performance - In 2024, the company reported revenues from various fertilizer products: biological compound fertilizer (6.75 billion yuan, +2.5%), phosphate fertilizer (6.66 billion yuan, +18.1%), potassium fertilizer (3.94 billion yuan, -25.0%), feed calcium (1.32 billion yuan, +6.1%), and specialty fertilizers (680 million yuan, +16.6%) [4]. - The total sales volume of fertilizers remained stable at 7.21 million tons, with biological compound fertilizer sales increasing by 10% and phosphate fertilizer sales rising by 12% [4]. Strategic Focus - The company is focusing on its "Bio+" strategy, which has led to an increase in the proportion of differentiated products in its compound fertilizer production from 6.8% in 2023 to 65.7% in 2024. The strategy emphasizes biological nitrogen fixation and phosphorus solubilization, resulting in a significant increase in sales of A-class products by 55% [5]. Profitability and Projections - The company's gross margin and net margin improved to 11.96% and 5.06%, respectively, reflecting a year-on-year increase of 1.56 percentage points and 1.91 percentage points [5]. - The analyst forecasts net profits for 2025, 2026, and 2027 to be 1.35 billion yuan, 1.48 billion yuan, and 1.60 billion yuan, corresponding to price-to-earnings ratios of 5.6, 5.1, and 4.8 times [7].

Investment Rating - The report maintains a "Buy-A" rating for the company [2][7] Core Views - The company has shown a steady growth in bio-composite fertilizers, benefiting from the continuous rise in potash prices. In 2024, the company achieved a revenue of 21.265 billion yuan, a year-on-year decrease of 2.1%, while the net profit attributable to the parent company increased by 69.7% to 1.061 billion yuan [3][4] - The company is focusing on a "Bio+" strategy, enhancing its profitability through product differentiation and improved production efficiency. The gross profit margin and net profit margin for 2024 were 11.96% and 5.06%, respectively, reflecting an increase of 1.56 percentage points and 1.91 percentage points year-on-year [5][7] Financial Performance Summary - In 2024, the company reported revenues from various fertilizer products: bio-composite fertilizers (6.75 billion yuan, +2.5%), phosphate fertilizers (6.66 billion yuan, +18.1%), potash fertilizers (3.94 billion yuan, -25.0%), and specialty fertilizers (0.68 billion yuan, +16.6%) [4] - The total sales volume of fertilizers in 2024 was 7.21 million tons, remaining stable compared to the previous year, with bio-composite fertilizer sales increasing by 10% [4] - The company expects net profits for 2025, 2026, and 2027 to be 1.35 billion yuan, 1.48 billion yuan, and 1.60 billion yuan, respectively, corresponding to P/E ratios of 5.6, 5.1, and 4.8 [7][9] Market Data - As of May 12, 2025, the closing price of the company's stock was 1.170 HKD, with a market capitalization of 8.219 billion HKD [2]

Investment Rating - The report maintains a "Buy" rating for Lenovo Group (0992.HK) [1][10]. Core Insights - Lenovo Group has launched the "Tianxi" super intelligent agent, marking a significant breakthrough in hybrid artificial intelligence, which serves as a cognitive operating system for individuals and enterprises [4]. - The introduction of the inference acceleration engine enhances Lenovo's AI PC competitiveness by optimizing hardware and software collaboration, addressing industry pain points related to model efficiency and computational power [4]. - With the expected increase in AI PC penetration from 18% in 2024 to 70% by 2028, Lenovo, as the leading global PC market player, is poised to benefit significantly [5]. Financial Projections - Revenue forecasts for Lenovo Group are projected at $67.658 billion, $74.763 billion, and $80.869 billion for FY2025, FY2026, and FY2027 respectively, with net profits expected to be $1.540 billion, $1.573 billion, and $1.966 billion for the same periods [5][8]. - The report anticipates a gradual improvement in Lenovo's performance as AI functionalities penetrate the PC market, with corresponding P/E ratios of 9.6x, 9.4x, and 7.5x for FY2025, FY2026, and FY2027 [5][8].